Navigation Links
NxStage Announces Second Quarter 2011 Investor Conference Schedule
Date:5/19/2011

LAWRENCE, Mass., May 19, 2011 /PRNewswire/ -- NxStage Medical, Inc. (Nasdaq: NXTM), a leading manufacturer of innovative dialysis products, today announced that Jeffrey H. Burbank, Chief Executive Officer, will participate in the following schedule of investor conferences.  A webcast of the event will be made available at http://www.nxstage.com/ir.cfm at the time of each conference.  

(Logo: http://photos.prnewswire.com/prnh/20110503/MM94799LOGO)

Jefferies 2011 Global Healthcare Conference
New York, NY
Thursday, June 9, 2011
8:00 a.m. ET

William Blair 2011 Growth Stock Conference
Chicago, IL
Four Seasons Hotel
Wednesday, June 15, 2011
10:00 a.m. CT

About NxStage Medical

NxStage Medical, Inc. (Nasdaq: NXTM) is a medical device company, headquartered in Lawrence, Massachusetts, USA, that develops, manufactures and markets innovative products for the treatment of end-stage renal disease, or ESRD, and acute kidney failure. For more information on NxStage and its products, please visit the company's website at http://www.nxstage.com.

Forward-Looking Statements

This release contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. All statements contained in this release that are not clearly historical in nature are forward-looking, and the words "anticipate," "believe," "expect," "estimate," "plan," and similar expressions are generally intended to identify forward-looking statements. Examples of these forward-looking statements include statements as to Mr. Burbank's plans to present at these conferences.  NxStage specifically disclaims any obligatio
'/>"/>

SOURCE NxStage Medical, Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine technology :

1. NxStage(R) to Recognize Several Key Milestones at American Society of Nephrologys Renal Week 2007
2. Boston Business Journal Names NxStage(R) Medical Third Fastest Growing Company in Massachusetts
3. NxStage(R) to Report Third Quarter 2009 Financial Results
4. NxStage(R) Reports Significant Interim FREEDOM Study Results
5. NxStage(R) and Nordic Medcom Sign Distribution Agreement for the System One(TM)
6. NxStage(R) Reports Third Quarter 2009 Financial Results and Raises Revenue Guidance for Fiscal 2009
7. Group of NxStage(R) Home Hemodialysis Patients to Take Caribbean Cruise with the System One(TM)
8. NxStage(R) Secures $15 Million Revolving Line of Credit
9. NxStage to Report Third Quarter Fiscal 2010 Financial Results
10. NxStage® Expands Product Portfolio With Innovative Patient Access Surveillance Solution From Vasc-Alert™
11. NxStage Announces Fourth Quarter 2010 Investor Conference Schedule
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2013)... WELWYN GARDEN CITY, England and ... Heptares Therapeutics, the leading GPCR drug discovery and development company, ... Akira Usui as a Consultant to augment the Company,s ... Asian territories. Mr Usui has more than 15 years ... pharmaceutical industry including senior roles at Perlegen Sciences, Inc., Roche Pharma ...
(Date:5/23/2013)... Neurocrine Biosciences, Inc. (Nasdaq: NBIX ) announced today ... Executive Officer of Neurocrine Biosciences, will be presenting at the ... in Boston.   The live presentation takes place ... 8:20 a.m. Pacific Time.  The presentation will be webcast and ... . If you are unable to attend ...
(Date:5/23/2013)... Hearing health affects a man,s lifestyle, and if ... and professionally engaged, he should address any hearing loss he ... Better Hearing Institute (BHI) is delivering to men ... Week , which leads up to and includes Father,s Day. ... through June 16. To help men address ...
Breaking Medicine Technology:Heptares Augments Business Development Capabilities in Japan and Other Asian Territories 2Men Who Want to Stay Active, Feel Younger, and Remain Socially and Professionally Engaged Should Address Hearing Loss, BHI Advises 2Men Who Want to Stay Active, Feel Younger, and Remain Socially and Professionally Engaged Should Address Hearing Loss, BHI Advises 3Men Who Want to Stay Active, Feel Younger, and Remain Socially and Professionally Engaged Should Address Hearing Loss, BHI Advises 4
... YORK, Nov. 14, 2011 Reportlinker.com announces ... available in its catalogue: ... http://www.reportlinker.com/p0203105/The-Outlook-for-Pharmaceuticals-in-Northern-Europe.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=NoCategory ... to represent a combined pharmaceutical market value ...
... MALVERN, Pa., Nov. 13, 2011 TetraLogic ... mimetic drugs to treat cancer, today announced presentations of ... TL32711 at the 2011 AACR-NCI-EORTC International Conference: Molecular ... nearing completion of a single agent Phase 1 study ...
Cached Medicine Technology:The Outlook for Pharmaceuticals in Northern Europe 2The Outlook for Pharmaceuticals in Northern Europe 3The Outlook for Pharmaceuticals in Northern Europe 4TetraLogic Pharmaceuticals Announces Presentation of Data on Smac Mimetic TL32711 at AACR-NCI-EORTC International Conference: Molecular Targets and Cancer Therapeutics 2
(Date:5/24/2013)... Chronic Fatigue Syndrome has been a mysterious ... fatigue lasting 6 months or longer. Symptoms of Chronic ... impairment, muscle and joint pain without swelling or redness, ... malaise that lasts for more than 24 hours. ... linked to insulin resistance. At a healthy body weight, ...
(Date:5/24/2013)... Concern have today released updated guidelines on Hormone Replacement ... HRT, the benefits and the risks. The new guidelines ... , published by SAGE. , Over the last ... "elixir of youth" to being considered extremely risky and ... publication of the Women,s Health Initiative (WHI) trial in ...
(Date:5/24/2013)... Wednesday, 15th May 2013 | 10am BST ... access webinar playback: http://bit.ly/10Rt0ZH , Ongoing regulatory changes ... Across the globe and particularly in Europe, a number of ... activity . For dealmakers, understanding how the likes of Basel ... affects your corner of the market will give you a ...
(Date:5/24/2013)... 2013 HCG EZ Drops has been ... to announce it’s new weight loss initiative. “We are so confident ... our customers their money back if they don’t lose 21 pounds ... EZ Drops. “The HCG Diet consists of 21 days of ... in 21 days.” , The controversial, cutting-edge diet has been hailed ...
(Date:5/24/2013)... UK (PRWEB) May 24, 2013 The leading ... 50% discount offer on short prom dresses . Now ... quality that is standard with the brand name since its ... collections in prom dresses. And now this huge discount offer ... , “I feel highly privileged to announce that ...
Breaking Medicine News(10 mins):Health News:hCGTreatments / Diet Doc hCG Diets & Weight Loss Plans Announces New hCG Diet Plans to Promote Fast Weight Loss Shown to Reduce the Risk & Symptoms of Chronic Fatigue 2Health News:hCGTreatments / Diet Doc hCG Diets & Weight Loss Plans Announces New hCG Diet Plans to Promote Fast Weight Loss Shown to Reduce the Risk & Symptoms of Chronic Fatigue 3Health News:Register to Access Webinar Playback - The Impact of Financial Regulation on M&A in 2013 2Health News:Register to Access Webinar Playback - The Impact of Financial Regulation on M&A in 2013 3Health News:short prom dresses Offers Abnormally Low Discount on Its New Collections 2
... readmitted within a year, study finds , , WEDNESDAY, April ... discharged from the hospital is readmitted within 30 days, ... a year, a new study finds. , The groundbreaking ... that researchers believe could be prevented through better care ...
... Calif., April 1, 2009 UC Irvine pharmacological researchers ... regulation can limit cocaine cravings. Their findings could herald ... Shinjae Chung and Olivier Civelli, the study identified how ... "pleasure center" to create an addictive response to cocaine ...
... NVAX) announced today that it has ... common stock at $0.88 per share to a wholly owned subsidiary ... Novavax and Cadila. Novavax intends to use the $11 million in ... 4.75% senior convertible notes due in July 2009 and for a ...
... April 1 Medicare beneficiaries who need physical ... efficient to obtain treatment under legislation introduced yesterday ... Patient Access to Physical Therapists Act (HR 1829), ... (R-PA), and Tammy Baldwin (D-WI), eliminates the need ...
... AILA believes this reform must include a rational model for giving American ... that can open the door to innovation and international markets. , ... ... fuel to speed it to recovery. And, once recovered, it ...
... April 1 On April 1st, Professional Healthcare Resources ... patients in their homes. The company was started in ... and has grown to an organization offering home health, ... of Columbia, and Virginia. The company has over 700 ...
Cached Medicine News:Health News:High Rate of Rehospitalizations Costing Billions 2Health News:High Rate of Rehospitalizations Costing Billions 3Health News:UCI researchers find new way to fight cocaine addiction 2Health News:Novavax Announces Closing of $11 Million Common Stock Sale to Subsidiary of Cadila Pharmaceuticals 2Health News:Legislation Aims to Increase Access to Physical Therapist Services By Eliminating Physician Referral Requirement 2Health News:Legislation Aims to Increase Access to Physical Therapist Services By Eliminating Physician Referral Requirement 3Health News:AILA Believes There Has To Be a Better Way When It Comes to the H-1B Lottery 2Health News:AILA Believes There Has To Be a Better Way When It Comes to the H-1B Lottery 3Health News:Professional Healthcare Resources Celebrates 15 Year Anniversary 2
... is the first truely web-based solution on the ... POC (managed from the lab) and Critical Care ... of AegisPOC ensures that all groups have the ... in the manner best suited to them. Through ...
...
... The Vari-Lase Endovenous Laser System is ... for varicose veins in the leg. Endovenous ... surgical vein-stripping for the treatment of varicose ... laser fiber is inserted into the varicosed ...
Using proven 1064 nm technology for the treatment of deeper lesions, the Lumenis One Multi-Spot Nd:YAG module provides versatility allowing targeted treatment of leg veins, vascular lesions, facial w...
Medicine Products: